Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates
Noel Salvoza, Pablo J. Giraudi, Claudio Tiribelli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2764-2764
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies
Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 454-499
Open Access | Times Cited: 30
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
Kailin Yang, Junpeng Chen, Tianqing Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis
Tingli Guo, Wenhui Yan, Xin Cui, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 26
Impact of Adherence to the Mediterranean Diet on Antioxidant Status and Metabolic Parameters in NAFLD Patients: A 24-Month Lifestyle Intervention Study
Maria Magdalena Quetglas‐Llabrés, Margalida Monserrat-Mesquida, Cristina Bouzas, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 480-480
Open Access | Times Cited: 6
Coffee Compounds Protection Against Lipotoxicity Is Associated with Lipid Droplet Formation and Antioxidant Response in Primary Rat Hepatocytes
Johanna C. Arroyave-Ospina, Magnolia Martínez-Aguilar, Manon Buist‐Homan, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 175-175
Open Access
Bioactive Small Compounds Effectively Inhibit ChREBP Overexpression to Treat NAFLD and T2DM: A Computational Drug Development Approach
Hiron Saraj Devnath, Maisha Maliha Medha, Md. Naharul Islam, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42477-e42477
Open Access
The Role of Phytosterols in Nonalcoholic Fatty Liver Disease
Otilia Elena Frăsinariu, Roxana Șerban, Laura Mihaela Trandafir, et al.
Nutrients (2022) Vol. 14, Iss. 11, pp. 2187-2187
Open Access | Times Cited: 26
Effect of Isoquercitrin on Free Fatty Acid-Induced Lipid Accumulation in HepG2 Cells
Sou Hyun Kim, Chawon Yun, Doyoung Kwon, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1476-1476
Open Access | Times Cited: 14
Dendrobium officinale alleviates high-fat diet-induced nonalcoholic steatohepatitis by modulating gut microbiota
Gege Tian, Wei Wang, Enrui Xia, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 14
The effect of DASH diet on glycemic response, meta-inflammation and serum LPS in obese patients with NAFLD: a double-blind controlled randomized clinical trial
Farnaz Rooholahzadegan, Sara Arefhosseini, Helda Tutunchi, et al.
Nutrition & Metabolism (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols
Raissa Bulaty Tauil, Paula Takano Golono, Enzo Pereira de Lima, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1354-1354
Open Access | Times Cited: 4
Carthamus tinctorius L. (Safflower) Flower Extract Attenuates Hepatic Injury and Steatosis in a Rat Model of Type 2 Diabetes Mellitus via Nrf2-Dependent Hypoglycemic, Antioxidant, and Hypolipidemic Effects
Nuha Saad Alshareef, Sahar Abdulaziz AlSedairy, Laila Naif Al‐Harbi, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1098-1098
Open Access | Times Cited: 3
The Effectiveness of Curcumin, Resveratrol, and Silymarin on MASLD: A Systematic Review and Meta‐Analysis
Qian Huang, Ziming An, Xin Xin, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 12, pp. 10010-10029
Open Access | Times Cited: 3
A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease
Yvelise Ferro, Roberta Pujia, Elisa Mazza, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 16
Multi-Omics Reveals Inhibitory Effect of Baicalein on Non-Alcoholic Fatty Liver Disease in Mice
Ping Li, Jianran Hu, Hongmei Zhao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials
Joel Yeh Siang Chen, Damien Chua, Carissa Odelia Lim, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 158-158
Open Access | Times Cited: 15
Protective effects of caffeine against palmitate-induced lipid toxicity in primary rat hepatocytes is associated with modulation of adenosine receptor A1 signaling
Johanna C. Arroyave-Ospina, Manon Buist‐Homan, Martina Schmidt, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 114884-114884
Open Access | Times Cited: 8
Integrating transcriptomics and network pharmacology to reveal the mechanisms of total Rhizoma Coptidis alkaloids against nonalcoholic steatohepatitis
Juan Li, Zhengcai Ma, Zhipeng Yang, et al.
Journal of Ethnopharmacology (2023) Vol. 322, pp. 117600-117600
Closed Access | Times Cited: 8
Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathway
Wenfei Yu, Guoliang Yin, Suwen Chen, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112581-112581
Closed Access | Times Cited: 2
Caffeic acid ameliorates metabolic dysfunction-associated steatotic liver disease via alleviating oxidative damage and lipid accumulation in hepatocytes through activating Nrf2 via targeting Keap1
Jinyu Zhang, Hao Ouyang, Xin-Nan Gu, et al.
Free Radical Biology and Medicine (2024) Vol. 224, pp. 352-365
Closed Access | Times Cited: 2
6-Shogaol Ameliorates Liver Inflammation and Fibrosis in Mice on a Methionine- and Choline-Deficient Diet by Inhibiting Oxidative Stress, Cell Death, and Endoplasmic Reticulum Stress
Ah Young Yang, Kiryeong Kim, Hyun Hee Kwon, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 419-419
Open Access | Times Cited: 1
Proteomic study of gamma-oryzanol preventive effect on a diet-induced non-alcoholic fatty liver disease model
Juliana Silva Siqueira, Jéssica Leite Garcia, Artur Júnio Togneri Ferron, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 127, pp. 109607-109607
Closed Access | Times Cited: 1
Unraveling the metabolic activities of bioactive compounds on cellular models of hepatosteatosis and adipogenesis through docking analysis with PPARs
Farah Diab, Hawraa Zbeeb, Lama Zeaiter, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty Liver Disease
Amir Avan, Ghazaleh Pourali, Zeinab Sadat Hosseini, et al.
Current Drug Targets (2023) Vol. 24, Iss. 4, pp. 300-319
Closed Access | Times Cited: 4
The impact and role of identified long noncoding RNAs in nonalcoholic fatty liver disease: A narrative review
Na Shi, Kang Sun, Haiying Tang, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 11-12
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top